Skip to content

Insulet PODD Price / book

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Medtronic logo
MedtronicMDT
2.1×-0.1×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
0.0×
Abbott logo
AbbottABT
3.4×-1.3×
Viatris logo
ViatrisVTRS
1.1×+0.4×

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Calculated from Insulet’s reported figures.

Based on the most recent quarter.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's price / book?
Insulet (PODD) reported price / book of 11.3× in Q1 2026.
How has Insulet's price / book changed year-over-year?
Insulet's price / book decreased by 18.2% year-over-year, from 13.9× to 11.3×.
What is the long-term trend for Insulet's price / book?
Over 5 years (2020 to 2025), Insulet's price / book has grown at a -14.7% compound annual growth rate (CAGR), from 29.2× to 13.2×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.